Trial Profile
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Abuse Potential of Sativex in Subjects With a History of Recreational Marijuana Use
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Jan 2022
Price :
$35
*
At a glance
- Drugs Nabiximols (Primary) ; Dronabinol
- Indications Cancer pain; Neuropathic pain
- Focus Pharmacokinetics
- Sponsors Jazz Pharmaceuticals Inc
- 30 Mar 2011 New trial record